ISPOR - PDG1- THE OUTCOMES OF LONG-TERM TREATMENT OF A NEW ORAL DIABETES DRUG PIOGLITAZONE (ACTOS ) IN THE MANAGEMENT OF TYPE 2 DIABETES IN FINLAND

Full Text

PDG1- THE OUTCOMES OF LONG-TERM TREATMENT OF A NEW ORAL DIABETES DRUG PIOGLITAZONE (ACTOS ) IN THE MANAGEMENT OF TYPE 2 DIABETES IN FINLAND

Abstract

Authors

N Maniadakis A Kielhorn K Heikkinen A Brandt R Jansen

Back to Volume 4, Issue 6

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now